SOLENO THERAPEUTICS INC Quarterly Current Ratio in % from Q2 2015 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Soleno Therapeutics Inc quarterly Current Ratio history and growth rate from Q2 2015 to Q3 2024.
  • Soleno Therapeutics Inc Current Ratio for the quarter ending September 30, 2024 was 1.73K %, a 824% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 1.73K +1.54K +824% Sep 30, 2024
Q2 2024 1.02K +809 +384% Jun 30, 2024
Q1 2024 632 +395 +167% Mar 31, 2024
Q4 2023 446 +135 +43.1% Dec 31, 2023
Q3 2023 187 -140 -42.8% Sep 30, 2023
Q2 2023 211 -125 -37.2% Jun 30, 2023
Q1 2023 237 -117 -33.1% Mar 31, 2023
Q4 2022 312 -55.9 -15.2% Dec 31, 2022
Q3 2022 327 -112 -25.6% Sep 30, 2022
Q2 2022 336 -197 -37% Jun 30, 2022
Q1 2022 354 -262 -42.5% Mar 31, 2022
Q4 2021 368 -207 -36% Dec 31, 2021
Q3 2021 440 -107 -19.5% Sep 30, 2021
Q2 2021 533 +70.1 +15.2% Jun 30, 2021
Q1 2021 616 +265 +75.7% Mar 31, 2021
Q4 2020 575 +55.2 +10.6% Dec 31, 2020
Q3 2020 546 -161 -22.7% Sep 30, 2020
Q2 2020 463 -312 -40.3% Jun 30, 2020
Q1 2020 350 -469 -57.2% Mar 31, 2020
Q4 2019 519 -269 -34.1% Dec 31, 2019
Q3 2019 707 -13.3 -1.84% Sep 30, 2019
Q2 2019 775 +47.3 +6.5% Jun 30, 2019
Q1 2019 819 +148 +22% Mar 31, 2019
Q4 2018 788 +189 +31.5% Dec 31, 2018
Q3 2018 720 +302 +72.3% Sep 30, 2018
Q2 2018 728 +311 +74.6% Jun 30, 2018
Q1 2018 671 +329 +96.1% Mar 31, 2018
Q4 2017 599 +328 +121% Dec 31, 2017
Q3 2017 418 +161 +62.8% Sep 30, 2017
Q2 2017 417 +247 +145% Jun 30, 2017
Q1 2017 342 +232 +211% Mar 31, 2017
Q4 2016 272 +144 +113% Dec 31, 2016
Q3 2016 257 +109 +73.9% Sep 30, 2016
Q2 2016 170 +14.7 +9.46% Jun 30, 2016
Q1 2016 110 Mar 31, 2016
Q4 2015 127 Dec 31, 2015
Q3 2015 148 Sep 30, 2015
Q2 2015 155 Jun 30, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.